ATE294593T1 - Inclusion-komplex von beta-cyclodextrin mit diclofenac - Google Patents
Inclusion-komplex von beta-cyclodextrin mit diclofenacInfo
- Publication number
- ATE294593T1 ATE294593T1 AT94307380T AT94307380T ATE294593T1 AT E294593 T1 ATE294593 T1 AT E294593T1 AT 94307380 T AT94307380 T AT 94307380T AT 94307380 T AT94307380 T AT 94307380T AT E294593 T1 ATE294593 T1 AT E294593T1
- Authority
- AT
- Austria
- Prior art keywords
- diclofenac
- cyclodextrin
- inclusion complex
- beta
- molecule
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nanotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA937480 | 1993-10-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE294593T1 true ATE294593T1 (de) | 2005-05-15 |
Family
ID=66767030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94307380T ATE294593T1 (de) | 1993-10-08 | 1994-10-07 | Inclusion-komplex von beta-cyclodextrin mit diclofenac |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5674854A (de) |
| EP (1) | EP0647451B1 (de) |
| JP (1) | JPH07196484A (de) |
| KR (1) | KR950010910A (de) |
| CN (1) | CN1161115C (de) |
| AT (1) | ATE294593T1 (de) |
| AU (1) | AU682887B2 (de) |
| CA (1) | CA2133885C (de) |
| DE (1) | DE69434356T2 (de) |
| ES (1) | ES2240960T3 (de) |
| IL (1) | IL111184A (de) |
| ZA (1) | ZA948078B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2735136B1 (fr) * | 1995-06-08 | 1997-08-14 | Roquette Freres | Composition pulverulente d'hydroxypropyl-betacyclodextrine et son procede de preparation. |
| HUP9600758A2 (en) * | 1996-03-27 | 1998-03-02 | Cyclolab Ciklodextrin Kutato F | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption |
| ATE248165T1 (de) * | 1999-07-01 | 2003-09-15 | Italfarmaco Spa | Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten |
| US7122376B2 (en) * | 2001-11-01 | 2006-10-17 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| US7049146B2 (en) | 2000-11-14 | 2006-05-23 | Facet Analytical Services And Technology, Llc | Calibration standards, methods, and kits for water determination |
| JP2005298338A (ja) * | 2002-02-27 | 2005-10-27 | Eisai Co Ltd | 速崩壊性圧縮成形製剤 |
| KR100473716B1 (ko) * | 2002-03-27 | 2005-03-08 | 주식회사 참 존 | 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법 |
| US20040131504A1 (en) * | 2002-09-17 | 2004-07-08 | Landers James P. | Remote temperature sensing of small volume and related apparatus thereof |
| FR2850040B1 (fr) * | 2003-01-20 | 2005-03-11 | Centre Nat Rech Scient | Systemes pour microencapsulation et leurs applications |
| ATE454905T1 (de) * | 2004-03-10 | 2010-01-15 | Shimoda Biotech Pty Ltd | Stabile injizierbare diclofenac- zubereitungen |
| RU2006141358A (ru) | 2004-04-23 | 2008-05-27 | Сайдекс, Инк. (Us) | Препаративная форма для ингалятора сухого порошка, содержащая простой сульфоалкиловый эфир циклодекстрина |
| US7629331B2 (en) * | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| DK2581078T3 (en) | 2005-10-26 | 2015-03-02 | Cydex Pharmaceuticals Inc | Sulfoalkylætercyclodekstrinsammensætninger and processes for the preparation thereof |
| US20070267033A1 (en) | 2006-02-09 | 2007-11-22 | Philip Morris Usa Inc. | Gamma cyclodextrin flavoring-release additives |
| JP5823093B2 (ja) | 2006-03-28 | 2015-11-25 | ジャヴェリン ファーマシューティカルズ インコーポレイテッド | 低投与量のジクロフェナク及びβ−シクロデキストリンの配合物 |
| US20070232567A1 (en) * | 2006-03-28 | 2007-10-04 | Curtis Wright | Formulations Of Low Dose Non-Steroidal Anti-Inflammatory Drugs And Beta-Cyclodextrin |
| FR2912061A1 (fr) * | 2007-02-01 | 2008-08-08 | Aliscience Soc Par Actions Sim | Complexes d'inclusion de cysteine, leur presparation et les compositions les contenant |
| DK2734212T3 (da) * | 2011-07-20 | 2017-11-06 | Hospira Inc | Sammensætninger omfattende diclofenac til behandling af postoperativ smerte |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5984821A (ja) * | 1982-11-04 | 1984-05-16 | Teikoku Chem Ind Corp Ltd | 徐溶化組成物 |
| IT1196033B (it) * | 1984-02-22 | 1988-11-10 | Chiesi Farma Spa | Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche |
| US4845188A (en) * | 1988-08-19 | 1989-07-04 | Eastman Kodak Company | Condensation polymers containing methine ultraviolet radiation-absorbing residues and shaped articles produced therefrom |
| MY106598A (en) * | 1988-08-31 | 1995-06-30 | Australian Commercial Res & Development Ltd | Compositions and methods for drug delivery and chromatography. |
| IT1241088B (it) * | 1990-03-27 | 1993-12-29 | Chiesi Farma Spa | Procedimento per la preparazione di complessi piroxicam/ciclodestrina,prodotti ottenuti e loro composizioni farmaceutiche |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| EP0519428B1 (de) * | 1991-06-21 | 2000-09-20 | Takeda Chemical Industries, Ltd. | Zyklodextrin-Zusammensetzung enthaltend Fumagillol-Derivate |
| DE4200792A1 (de) * | 1992-01-15 | 1993-07-22 | Solvay Fluor & Derivate | Aufarbeitung der fluorwasserstoff-phase aus reaktionsgemischen |
| JPH0616547A (ja) * | 1992-07-01 | 1994-01-25 | Wakamoto Pharmaceut Co Ltd | 消炎点眼剤 |
-
1994
- 1994-10-06 IL IL11118494A patent/IL111184A/xx not_active IP Right Cessation
- 1994-10-07 AT AT94307380T patent/ATE294593T1/de not_active IP Right Cessation
- 1994-10-07 AU AU74486/94A patent/AU682887B2/en not_active Ceased
- 1994-10-07 DE DE69434356T patent/DE69434356T2/de not_active Expired - Lifetime
- 1994-10-07 US US08/319,548 patent/US5674854A/en not_active Expired - Lifetime
- 1994-10-07 ES ES94307380T patent/ES2240960T3/es not_active Expired - Lifetime
- 1994-10-07 EP EP94307380A patent/EP0647451B1/de not_active Expired - Lifetime
- 1994-10-07 KR KR1019940025644A patent/KR950010910A/ko not_active Application Discontinuation
- 1994-10-07 CA CA002133885A patent/CA2133885C/en not_active Expired - Fee Related
- 1994-10-08 CN CNB941186768A patent/CN1161115C/zh not_active Expired - Fee Related
- 1994-10-11 JP JP6271715A patent/JPH07196484A/ja active Pending
- 1994-10-14 ZA ZA948078A patent/ZA948078B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2133885C (en) | 2008-12-16 |
| DE69434356T2 (de) | 2006-05-04 |
| KR950010910A (ko) | 1995-05-15 |
| IL111184A (en) | 2000-08-13 |
| CN1107042A (zh) | 1995-08-23 |
| ZA948078B (en) | 1995-06-05 |
| CN1161115C (zh) | 2004-08-11 |
| ES2240960T3 (es) | 2005-10-16 |
| AU7448694A (en) | 1995-04-27 |
| IL111184A0 (en) | 1994-12-29 |
| JPH07196484A (ja) | 1995-08-01 |
| CA2133885A1 (en) | 1995-04-09 |
| EP0647451B1 (de) | 2005-05-04 |
| US5674854A (en) | 1997-10-07 |
| AU682887B2 (en) | 1997-10-23 |
| DE69434356D1 (de) | 2005-06-09 |
| EP0647451A1 (de) | 1995-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE294593T1 (de) | Inclusion-komplex von beta-cyclodextrin mit diclofenac | |
| ES2118283T3 (es) | Derivados de acidos benzofuranil- y -tiofenil-alcanocarboxilicos. | |
| FI96204C (fi) | Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi | |
| KR890003720A (ko) | 벤조티아졸 및 그를 유효성분으로 함유하는 항류머티스제 | |
| DK0569802T3 (da) | Arylacetamider | |
| ES2105362T3 (es) | Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos. | |
| ATE144498T1 (de) | Herstellung von substituierten piperidinen | |
| ATE159713T1 (de) | N-acylglutamin-derivate | |
| DK0623620T3 (da) | 5-HT3-pyrrolopyrazinderivater | |
| ATE92070T1 (de) | Azachromanderivate. | |
| DE69108580D1 (de) | Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen. | |
| ES2062313T3 (es) | 13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos. | |
| FI960588A (fi) | Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä | |
| PE50296A1 (es) | Eter substituido con tiazol y oxazol biciclico | |
| DE69815347D1 (de) | Tetrahydrofuranderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |